Guardant Health
GH
#1089
Rank
S$29.16 B
Marketcap
S$217.30
Share price
3.64%
Change (1 day)
166.58%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): S-$4.35

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is S-$4.31. In 2025 the company made an earnings per share (EPS) of S-$4.21 an increase over its 2024 EPS that were of S-$4.53.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$4.353.3%
2025S-$4.21-7.02%
2024S-$4.53-16.82%
2023S-$5.44-33.12%
2022S-$8.1460%
2021S-$5.0955.04%
2020S-$3.28207.14%
2019S-$1.07-19.81%
2018S-$1.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
S-$3.57-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
S-$3.15-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA